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A new abnormal hemoglobin Hb Le Lamentin (~20 (Bl) His-Gln was discovered during a survey of cord 
blood from the French West Indies (Martinique). This variant displays an electrophoretic pattern similar 
to that of Hb A but can be isolated by isoelectric focusing (IEF) and Biorex 70 chromatography. Family 
studies showed the presence of this hemoglobin variant in the father and in two of his three children. 
Hematological data from the carriers were normal. 
Hemoglobin Le Lamentin a20 (BI) His-+Gln Silent Hb variant (Corol blood) (Isoelectric focusing) 
1. INTRODUCTION 
We described in the present paper a new elec- 
trophoretically and clinically silent hemoglobin 
variant discovered during a mass screening of cord 
blood by isoelectric focusing. The great majority of 
clinically silent variants have been detected by 
conventional procedures as a result of routine 
screening of selected populations and because they 
presented aclear difference in their electrophoretic 
pattern. 
In the present case isoelectric focusing was the 
only electrophoretic method giving a clear separa- 
tion of the variant and therefore permitting its de- 
tection. 
2. MATERIALS AND METHODS 
Hematological studies were done by routine 
procedure using a Coulter counter model S. Elec- 
trophoretic studies were performed on cellulose 
acetate strip (Sebia) with Tris, EDTA, borate 
buffer (pH 8.6). Isoelectric focusing was done on 
thin-layer polyacrylamide gel as previously de- 
scribed [l]. Citrate agar electrophoresis of Hb at 
pH 6.0, globin chain electrophoresis in urea 8 M at 
pH 6.0 and pH 9.0 were performed according to 
standard procedures. 
Whole blood affinity for 02 was determined on 
a Hem-O-Scan (Aminco, Silver springs MD). 
Erythrocyte 2,3-DPG-concentration was measured 
according to the method in [2]. Stability of Hb was 
tested by isopropanol test [3]. Hemoglobin A2 was 
evaluated by microchromatography on DE-52 col- 
umn with glycine (0.2 M) KCN buffer [4] and Hb 
F by alkali denaturation as described in [5]. 
The abnormal fraction was isolated by chro- 
matography on Biorex 70 (Biorad) [6] according to 
a modification of the method in [7]. 
After deheminization by acid acetone precipita- 
tion, the chains were separated as in [8] and made 
free of urea on a Biogel P2 (Biorad) column. The 
tryptic peptides of the a-amino ethylated chain 
were separated by finger-print on silicagel thin 
layer plates (91, eluted, submitted to hydrochloric 
acid hydrolysis. The amino acid composition was 
determined on a Biotronik 6000 1E (Biotronik, 
Munich). 
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3. RESULTS 
The abnormal Hb was discovered, during a rou- 
tine screening performed by IEF [lo] for Hb S and 
C on the new born negroes at Fort de France, 
Martinique. Family study showed the presence of 
this variant in the father and in an another child. 
No clinical or hematological abnormalities were 
found in association with this hemoglobin. The 
isopropanol test was negative. The PSO of whole 
blood of the father was 3 1 mmHg (n = 28 + 1) and 
the 2,3-DPG level was normal: 12.85 pmol/g Hb 
(n = 15 + 2). Identification and structural studies 
were performed on a father’s sample. At alkaline 
pH, the electrophoretic pattern was indistinguish- 
able from that of the normal one. The variant mi- 
grated as Hb A on citrate agar electrophoresis 
(pH 6.00). By IEF the abnormal component, repre- 
senting 20% of the total, focused slightly more 
anodically than Hb Al,. 
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Fig.1. Purification of the abnormal fraction by column 
chromatography 800 mg of hemolysate were separated 
on a column of Biorex 70 (200-400 Msh) diam. 2.5 x 
18 cm, equilibrated with a sodium phosphate buffer 
(0.048 M) pH 6.75. The fractions which contain the 
‘non-heme protein’ (N.H.P.) Hb At, and Hb Atb were 
eluted with the equilibrium buffer A. The other frac- 
tions were eluted stepwise using NaCl concentration: 
0.1 N NaCl for Hb At, and Hb Le Lamentin (Buffer B); 
0.3 N NaCl for Hb Ac and Hb A2 (Buffer C). Control by 
IEF of the hatched fraction showed a single band of 
pure Hb Le Lamentin. 
Fig.2. Finger print of the tryptic digest of aAE Le La- 
mentin at pH 6.4 on a silica gel layer plate. The dotted 
circle shows that the spot of the cyAT4 peptide is absent. 
The arrow indicates the spot of the new peptide aT4. 
Globin chain electrophoresis in urea 8 M at 
pH 9.00 demonstrated the presence of an abnor- 
mal cu chain which was not detected at pH 6.0. The 
abnormal hemoglobin could be obtained pure by 
chromatography on Biorex 70 (lig.1). The finger 
print map of the (Y variant tryptic peptides is 
shown on tig.2. The normal peptide aT4 is absent 
and a more anodic new peptide is visible. Specific 
staining of this new peptide gave a positive reac- 
tion for tyrosine and arginine and a negative one 
for histidine. 
The amino acid composition of this peptide 
(table 1) showed an aT4 stoichiometry except for 
Table 1 
Amino acid composition of peptide aT4 
Hb Le Lamentin HbA 
Glu 4 3 
G’Y 3 3 
Ala 4 4 
Val 1 1 
Leu 1 1 
Tyr 1 1 
His 0 1 
A rg 1 T 
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the replacement of the His 20 by a glutamine or a 
glutamic acid. 
Evidence that hemoglobin Le Lamentin (uT4 
peptide contains glutamine rather than glutamic 
acid resulted from the following considerations: 
Glu instead of Gln in the aT4 peptide would pro- 
duce a more anodic position in urea elec- 
trophoresis of the chains at pH 6.0; the presently 
accepted coding assignment allows His-+Gln in 
one step transition but exclude His-+Glu. 
The substitution His+Gln is moreover the only 
compatible one, according to genetic code data 
with only one base replacement. Since the codon 
for His a20 is CAC [ 111, the substitution is likely 
CAC-CAA. 
4. DISCUSSION 
We have described a new variant of the (Y chain 
(r20 His-Gln which is clinically and biologically 
silent. The standard electrophoretic procedure 
failed to detect the abnormal band. 
This result gives another example of the high re- 
solving power of IEF screening method [l]. The 
His-Gln transition has not been previously de- 
scribed in (Y variants despite the presence of several 
cases involving a histidine substitution. In con- 
trast, it has been observed in two instances in the 
P-chain: Hb St Etienne B92 His-Gln [ 121 and Hb 
Malmo fi97 His-Gln [ 131. The abnormal peptides 
of the three variants exhibited approximately the 
same difference of mobility compared to their nor- 
mal control. But in IEF, Hb Le Lamentin migrates 
approximately as Hb Malmo in contrast to Hb St 
Etienne which is not separated from Hb A except 
for its deheminized form. This is likely a con- 
sequence of the rather external position of (~20 and 
p97. 
Another substitution of His (~20 has been de- 
scribed in Hb Necker-Enfants Malades [ 141. Sever- 
al similarities are present between Hb Le Lamen- 
tin and Hb Necker-Enfants Malades. They have 
been found in two subjects originated from French 
West Indies, they do not produce clinical abnor- 
mality and are well purified by chromatography 
on Biorex 70. 
According to the results obtained by Wischner 
[ 151 the residue His a20 may participate in an ionic 
bond with Glu /322 of a neighboring molecule dur- 
ing the polymerisation of the Hb’s tetramers. Fur- 
ther work is underway to test this hypothesis. 
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